Browse: Top 500 Logos

EUPREL

EUPREL logo

On 5/22/1998, a U.S. federal trademark registration was filed for EUPREL. This trademark is owned by ALZA Corporation,
1900 Charleston Road
Mountain View, CA 940397210. The USPTO has given the EUPREL trademark serial number of 75489660.

Word Mark: EUPREL
Filing Date: 5/22/1998
Goods and Services: Pharmaceutical preparations, namely, an LH-RH agonist preparations for use in the treatment of cancer; implantable drug delivery systems comprised of an impermeable reservoir, a piston, a water-swellable agent formulation, an LH-RH agonist formulation, a semi-permeable plug, and a back-diffusion regulating outlet for use in the treatment of cancer
Type Of Mark: TradeMark
Latest Owner: ALZA Corporation

1900 Charleston Road
Mountain View, CA 940397210
Correspondent: PAULINE ANN CLARKE
ALZA CORPINTELLECTUAL PROPERTY DEPT950 PAGE MILL RDPALO ALTO CA 943031
Related Tags: Pharmaceutical preparations namely - agonist preparations treatment cancer implantable drug delivery systems comprised impermeable reservoir piston water-swellable agent formulation - agonist formulation semi-permeable plug back-diffusion regulating outlet treatment cancer
US Class Code(s): 006, 018, 044, 046, 051, 052
Primary Class: Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Class(es) Status: Active
First Use Anywhere: NOT PROVIDED
Information: You are viewing the EUPREL logo. The name EUPREL is registered as a TradeMark by the company ALZA Corporation. This company is located on:
1900 Charleston Road
Mountain View, CA 940397210.
EUPREL sells goods and services of Pharmaceutical preparations, namely, an LH-RH agonist preparations for use in the treatment of cancer; implantable drug delivery systems comprised of an impermeable reservoir, a piston, a water-swellable agent formulation, an LH-RH agonist formulation, a semi-permeable plug, and a back-diffusion regulating outlet for use in the treatment of cancer. This logo and TradeMark was filed on May 22, 1998 and was first used on January 01, 1970.